相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Monoclonal Antibody TB-403: A First-in-Human, Phase I, Double-Blind, Dose Escalation Study Directed Against Placental Growth Factor in Healthy Male Subjects
Titti Martinsson-Niskanen et al.
CLINICAL THERAPEUTICS (2011)
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative, Locally Recurrent or Metastatic Breast Cancer
Nicholas J. Robert et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy
Jenny Yao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement
A. P. Taylor et al.
BRITISH JOURNAL OF CANCER (2010)
EXPRESSION OF PLACENTA GROWTH FACTOR: AN INDEPENDENT FACTOR FOR PREDICTION OF PROGRESSION AND PROGNOSIS OF ORAL CANCER
Shih-Jung Cheng et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2010)
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
David W. Miles et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Placenta Growth Factor Expression Has Prognostic Value in Malignant Pleural Mesothelioma
Eugenio Pompeo et al.
ANNALS OF THORACIC SURGERY (2009)
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
Christian Fischer et al.
NATURE REVIEWS CANCER (2008)
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Kathy Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Placenta growth factor not vascular endothelial growth factor A or C can predict the early recurrence after radical resection of hepatocellular carcinoma
Ming-Chih Ho et al.
CANCER LETTERS (2007)
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system
Clifford A. Hudis et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
HER-2 protein concentrations in breast cancer cells increase before immunohistochemical and fluorescence in situ hybridization analysis turn positive
Dorte A. Olsen et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2007)
Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor
Marcella Marcellini et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Placenta growth factor is over-expressed and has prognostic value in human breast cancer
C Parr et al.
EUROPEAN JOURNAL OF CANCER (2005)
Placenta growth factor expression is correlated with survival of patients with colorectal cancer
SC Wei et al.
GUT (2005)
The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer
CN Chen et al.
CANCER LETTERS (2004)
Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
M Autiero et al.
NATURE MEDICINE (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Revision of the American Joint Committee on Cancer staging system for breast cancer
SE Singletary et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Structure and function of placental growth factor
S De Falco et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2002)
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
P Carmeliet et al.
NATURE MEDICINE (2001)
Mechanisms of angiogenesis and arteriogenesis
P Carmeliet
NATURE MEDICINE (2000)
分享论文
